We have reported that testosterone replacement increased TH protein levels in the substantia nigra in adolescent male rats , however, we now show that contrary to our prediction that testosterone would increase TH in the striatum as well, no increase in striatal TH protein or increase in striatal dopamine levels was detected. Differences in dopamine pathway-related gene expression between intact and gonadectomised rats in our study may be subtle and difficult to detect due to differences between the natural gradual increase in testosterone over adolescence and the immediate, supraphysiological, steady state levels achieved with implants. Further, the increase in DAT and VMAT mRNAs by testosterone was not accompanied by changes in TH protein or dopamine levels in the striatum perhaps suggesting that synthesis and steady state levels are stable at the terminals, whereas in the substantia nigra both TH and DAT protein are increased by testosterone. This novel data, combined with our previous findings of increased TH protein and COMT and MOA mRNAs in the substantia nigra with testosterone during an adolescent period (PND45-60), suggests that the dopaminergic system may be coordinately modified to accommodate more midbrain dopamine signaling when males mature. Our results indicate that in adolescent male rats, testosterone may alter the dopamine neurotransmission within the nigrostriatal pathway by attenuating dopamine turnover in the striatum and by modulating mRNA levels of dopamine receptors and changing dopamine transporter levels in the midbrain.
The result of blocking this enzyme is that there’s a buildup of acetylcholine in the synapse and continuous activation of the cholinergic receptors. Within your brain, acetylcholine is also involved in motivation, arousal, attention, learning and promoting rapid eye movement (REM) sleep. Both types of receptors are involved in memory, including long-term and working memory, memory formation and consolidation and retrieval. Two weeks of castration caused a 48% loss of acetylcholine receptors in this muscle. In the brain it is unlikely that choline acetyltransferase is saturated with either of its substrates, so that choline (and possibly acetyl-CoA) availability determines the rate of acetylcholine synthesis.
Further studies in adult rats suggest other components of dopamine signaling can also be modified by androgens , –. Understanding the molecular mechanisms by which testosterone modulates the maturation and regulation of nigrostriatal dopamine responsivity during adolescence is crucial to understanding the possible role of testosterone in schizophrenia risk. Increased dopamine within the nigrostriatal pathway of patients with schizophrenia is proposed as a driver of psychosis – supported by the effectiveness of antipsychotics (which block dopamine D2 receptors) in diminishing symptoms of hallucinations and delusions .
A priori, planned comparisons, based on mRNA data, revealed that testosterone replacement increased DAT protein compared to the gonadectomised group. Gene expression for dopamine transporters (DAT and VMAT2) and protein levels of DAT were increased in the substantia nigra by androgens but not estradiol. Unexpectedly, dopamine was unchanged in the dorsal striatum by gonadectomy or with testosterone replacement, but dopamine turnover was increased by gonadectomy. In addition, gonadectomy reduced TH activity in the striatum of adult male rats and this reduction was prevented by testosterone .We recently reported that testosterone increased COMT and MAO mRNAs in the adolescent male rat substantia nigra (SN), implying increased dopamine turnover capacity in the nigrostriatal pathway in male adolescence .
Compounding these AR-driven effects is our evidence that in addition to modulating dopamine regulating proteins and mRNAs, testosterone also creates a self-reinforcing, positive feedback loop in the adolescent male rat midbrain to create a more androgen responsive state by increasing AR gene expression whilst decreasing ERα gene expression . The testosterone-induced changes we report in DRD2 gene expression in the nigrostriatal pathway at adolescence are of particular interest as DRD2 receptors are the target of all antipsychotic treatments for schizophrenia, with DRD2 receptors in the dorsal striatum suggested to be the most responsive to changes in tissue dopamine levels . We also report increased DRD2 gene expression in response to testosterone in both the region of the dopaminergic cell bodies and in the region of the medium spiny neurons of the dorsal striatum. In fact, dopamine turnover (a measure of dopamine activity) in the striatum was increased upon testosterone removal and this stimulatory effect was attenuated by testosterone replacement. In the substantia nigra, testosterone increased several dopamine receptor mRNAs D1, D2 (short and long), D5 as well as dopamine transporter (VMAT2, DAT) gene expression and DAT protein but decreased DRD3 mRNA.
In control rats, RPA showed the presence of mRNA for M1, M2 and M3 mAChR in the caput and cauda epididymis. The rat androgen status was monitored by measuring plasma testosterone level and caput and cauda epididymis wet weight. Cleveland Clinic’s health articles are based on evidence-backed information and review by medical professionals to ensure accuracy, reliability and up-to-date clinical standards. Acetylcholine (ACh) is an important neurotransmitter that plays a role in brain functions, such as memory, and body functions, such as muscle contractions to move your muscles. Supplements that stop the breakdown of acetylcholine include Bacopa monnieri, Ginkgo biloba and huperzine A.

Gender: Female

Social links